In this issue:
- Pan-PPAR agonist lanifibranor in NASH
- Bariatric surgery for non-alcoholic steatohepatitis
- Entecavir vs tenofovir for HCC prevention
- Long-term follow-up of IFN-α for HBeAg-positive chronic HBV
- HCV-related liver transplantation in Australia and New Zealand
- GP education programme for diagnosis and treatment of chronic HCV
- Liver inflammation in Asian patients with chronic HBV with normal ALT
- HCV eradication improves cognitive function
- Effectiveness of broad access direct-acting antivirals for hepatitis
- Outcomes in adults with NAFLD
Please login below to download this issue (PDF)